Alpha Tau Medical Ltd. (DRTSW)

R&D Expense Growth

14.11%

Fiscal year · Period ending:

DRTSW logo

DRTSW R&D Expense Growth

Latest reported14.11%
DRTSW FY R&D Growth (YoY) (0.00% → 14.11%)
High-resolution chart · PNG

DRTSW r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Alpha Tau Medical Ltd. R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
14.1118%
2.2555%
26.4911%
82.4932%
53.4862%
12.387%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.